--BioVaxys Technology Corp. is pleased to announce that it has been invited to and joined The Rapid Response Partnership Vehicle, a consortium of large and small biopharma, contractors, government ...

News about Biomedical Advanced Research and Development Authority. Commentary and archival information about Biomedical Advanced Research and Development Authority from The New York Times.

GNOMX Corp. has been awarded a $749,700 contract by the Division of Research, Innovation, and Ventures (DRIVe) within the Biomedical Advanced Research and Development Authority (BARDA), part of ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the ...

Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...

Empatica's FDA-cleared platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction ...

Department of Health and Human Services, valued at $41.9 million, for drug substance engineering and scale-up process validation, long term stability, and commercial readiness in support of its ...

Morningstar brands and products Company Portfolio ...

Article ‘Count’ and ‘Share’ for HHS Biomedical Advanced Research and Development Authority (BARDA) based on listed parameters only. The articles listed below published by authors from HHS ...

VANCOUVER, BC, Nov. 5, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to ...

Overall Count and Share for 'HHS Biomedical Advanced Research and Development Authority (BARDA)' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one ...